Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- VERITAS: Amulet 360 LAAO Safe, EffectiveThe Amulet 360, Abbott's next-generation dual-seal left atrial appendage occlusion (LAAO) device, is effective and safe at 45 days according to the results of the VERITAS study published Feb. 6 in JACC: Clinical Electrophysiology.
- TUXEDO-2: Ticagrelor vs. Prasugrel in PCI Patients With Diabetes and MVDTicagrelor was not shown to be noninferior to prasugrel for the reduction of the primary composite endpoint of death, nonfatal myocardial infarction (MI), stroke or major bleeding at one year in patients with diabetes and multivessel coronary disease (MVD) undergoing PCI...
- Million Veteran Program Analysis: Higher CV Risk in Patients With ATTRv V142I VariantAmong individuals with African ancestry, veterans with the V142I variant, the most common one underlying variant amyloidogenic transthyretin (ATTRv) amyloidosis, have a significantly higher risk for heart failure (HF) or cardiomyopathy, HF-related hospitalization, atrial fibrillation (AFib) or atrial flutter...
- Are Cardiac Myosin Inhibitors the Real Deal? Aficamten vs. Beta-Blocker MonotherapyHypertrophic cardiomyopathy (HCM) has become increasingly prevalent worldwide, especially in the era of genetic screening. However, the recent introduction of cardiac myosin inhibitors (CMIs) and their proven efficacy in reducing the degree of left ventricular outflow tract obstruction (LVOTO)...
- ACCEL Lite: NOTIFY-PICTURE Trial: Real-Time Notification of AI-Derived Incidental CAC on Statin InitiationIn this interview, C. Noel Bairey Merz MD, MACC and Ramzi Dudum MD, FACC discuss the NOTIFY-PICTURE Trial: Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription.